Sumitomo Pharma Market Cap

Sumitomo Pharma has a market cap or net worth of $2.64 billion as of May 9, 2025. Its market cap has increased by 152.05% in one year.

Market Cap

2.64B

Enterprise Value

4.63B

Revenue

2.37B

Ranking

n/a

PE Ratio

n/a

Stock Price

$6.53

Market Cap Chart

Since January 14, 1992, Sumitomo Pharma's market cap has increased from 1.62B to 2.64B, an increase of 62.49%. That is a compound annual growth rate of 1.47%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	2.64B	85.43%
Dec 30, 2024	1.42B	8.36%
Dec 29, 2023	1.31B	-56.36%
Dec 30, 2022	3.01B	-34.17%
Dec 30, 2021	4.57B	-21.94%
Dec 30, 2020	5.86B	-24.66%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	761.86M
Tian'an Technology Group	568.98M
Glass House Brands	478.11M
Elite Pharmaceuticals	468.54M
CytoDyn	417.40M
Northwest Biotherapeutics	389.52M

Market Cap Rankings